N < sup > 6 < /sup > -methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges
CONCLUSIONS: Our findings unveil a previously uncharted mechanism underpinning cisplatin resistance and advocate the potential therapeutic targeting of circ_104797 in cisplatin-administered patients with BCa, offering a promising avenue for advanced BCa management.PMID:38395751 | PMC:PMC10893648 | DOI:10.1186/s11658-024-00543-3
Source: Cellular and Molecular Biology Letters - Category: Biochemistry Authors: Congjie Xu Jiaquan Zhou Xiaoting Zhang Xinli Kang Shuan Liu Mi Song Cheng Chang Youtu Lin Yang Wang Source Type: research
More News: Biochemistry | Biology | Bladder Cancer | Cancer | Cancer & Oncology | Molecular Biology | Vitamin B7